Working with investigators for CNS therapeutics from around the world enables Clinilabs Drug Development Corporation to conduct global-multicenter clinical trials. At Clinilabs, we identify investigators based on their experience, as well as their ability to recruit patient populations of interest to our sponsors. Registered investigators become eligible to receive feasibility assessments for clinical trials under consideration by our sponsor companies. Additionally, registration enables you to identify your therapeutic areas of interest, the capabilities of your investigator site staff, and the features of your facility that support the conduct of clinical trials.

Clinilabs commonly canvases its investigators for CNS therapeutics through our proprietary investigator site database when sponsors request information about study feasibility. Interested investigators may request information regarding experience, capabilities, and ability to enroll subjects. We may also provide specific information regarding sponsor protocols which investigators can use to evaluate the scientific merits of a particular study. This evaluation enables investigators to determine if study participation is right for them.

At Clinilabs, we value the critique of our protocols by investigators and draw upon these suggestions as a way to continually improve our processes. We consider this feedback an integral part of the scientific process which enables us to provide commentary back to our study sponsors allowing for a smooth study experience for all.

Clinilabs specializes in the development of CNS therapeutics and is always looking for experienced investigators for CNS therapeutics to join our team. Therefore, we ask investigators to identify the specific areas of expertise that you may have.